Published in Herzschrittmacherther Elektrophysiol on September 20, 2012
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA (2005) 3.89
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med (2009) 3.35
Challenges in the clinical application of whole-genome sequencing. Lancet (2010) 2.92
Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl) (2004) 2.81
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol (2003) 2.47
Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation (2005) 2.42
Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol (2008) 2.39
A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol (2005) 2.21
Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med (2006) 2.16
Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol (2008) 1.97
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J (2008) 1.76
Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ Arrhythm Electrophysiol (2009) 1.74
Importance of Knowing the Genotype and the Specific Mutation When Managing Patients with Long QT Syndrome. Circ Arrhythm Electrophysiol (2008) 1.48
Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc (1999) 1.32
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. Europace (2011) 1.14
Inherited cardiac arrhythmias: diagnosis, treatment, and prevention. Dtsch Arztebl Int (2011) 1.01
Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm (2008) 0.95
Cardiac gene defects can cause sudden cardiac death in young people. Dtsch Arztebl Int (2009) 0.89
High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet (2005) 0.87
Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J (2007) 0.87
Dual inheritance of sudden death from cardiovascular causes. N Engl J Med (2008) 0.85
Cost-effectiveness of genotyping in inherited arrhythmia syndromes: are we getting value for the money? Circ Arrhythm Electrophysiol (2009) 0.78
When is genetic testing useful in patients suspected to have inherited cardiac arrhythmias? Curr Opin Cardiol (2010) 0.77
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet (2006) 6.39
Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet (2009) 4.10
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80
Genome-wide association study of PR interval. Nat Genet (2010) 3.73
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55
Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. J Am Coll Cardiol (2006) 2.73
Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation (2013) 2.66
Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J (2006) 2.54
Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest (2008) 2.54
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc (2013) 2.47
Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest (2011) 2.38
Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol (2008) 2.37
Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J (2012) 2.30
Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ Res (2005) 2.23
Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol (2009) 2.20
The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur Heart J (2008) 2.10
Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Heart Rhythm (2012) 1.91
Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation (2010) 1.90
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet (2013) 1.86
Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res (2005) 1.86
Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol (2012) 1.81
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Genome-wide association analysis identifies multiple loci related to resting heart rate. Hum Mol Genet (2010) 1.67
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet (2009) 1.59
Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm (2010) 1.58
Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA). PLoS Med (2010) 1.56
Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study. Europace (2009) 1.45
Genome-wide association studies in cardiac electrophysiology: recent discoveries and implications for clinical practice. Heart Rhythm (2010) 1.45
Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation (2009) 1.41
A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project. Circ Cardiovasc Genet (2009) 1.35
MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation (2013) 1.33
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. Circ Cardiovasc Genet (2014) 1.27
Genome-wide association studies of atrial fibrillation: past, present, and future. Cardiovasc Res (2011) 1.27
Functional profiling of human atrial and ventricular gene expression. Pflugers Arch (2005) 1.21
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation (2014) 1.11
Impact of real-time contact force and impedance measurement in pulmonary vein isolation procedures for treatment of atrial fibrillation. Clin Res Cardiol (2013) 1.09
Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project. Circ Cardiovasc Genet (2011) 1.06
Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol (2010) 1.05
Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes. PLoS One (2013) 1.04
Usefulness of short-term variability of QT intervals as a predictor for electrical remodeling and proarrhythmia in patients with nonischemic heart failure. Am J Cardiol (2010) 1.02
The common non-synonymous variant G38S of the KCNE1-(minK)-gene is not associated to QT interval in Central European Caucasians: results from the KORA study. Eur Heart J (2007) 1.01
Inherited cardiac arrhythmias: diagnosis, treatment, and prevention. Dtsch Arztebl Int (2011) 1.01
Genetics of atrial fibrillation: implications for future research directions and personalized medicine. Circ Arrhythm Electrophysiol (2010) 1.01
Common genetic variants in ANK2 modulate QT interval: results from the KORA study. Circ Cardiovasc Genet (2008) 0.99
Atrial Arrhythmias in long-QT syndrome under daily life conditions: a nested case control study. J Cardiovasc Electrophysiol (2008) 0.96
Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels. Circ Res (2008) 0.95
Relation of increased short-term variability of QT interval to congenital long-QT syndrome. Am J Cardiol (2009) 0.95
Modified serum profiles of inflammatory and vasoconstrictive factors in patients with emotional stress-induced acute coronary syndrome during World Cup Soccer 2006. J Am Coll Cardiol (2010) 0.94
Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur Heart J (2011) 0.92
Endobronchial lipomatous hamartoma: an incidental finding in a patient with atrial fibrillation-a case report. Case Rep Med (2012) 0.92
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J (2013) 0.92
Of rodents and humans: a light microscopic and ultrastructural study on cardiomyocytes in pulmonary veins. Int J Med Sci (2008) 0.91
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb Haemost (2011) 0.87
Dual inheritance of sudden death from cardiovascular causes. N Engl J Med (2008) 0.85
Marked differences between atrial and ventricular gene-expression remodeling in dogs with experimental heart failure. J Mol Cell Cardiol (2008) 0.84
Is Pitx2 growing up? Circ Cardiovasc Genet (2011) 0.83
The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes. Eur Heart J (2012) 0.83
Ivabradine in patients with inappropriate sinus tachycardia. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.82
QTc interval prolongation in children with Ulrich-Turner syndrome. Eur J Pediatr (2006) 0.82
A multimetric approach to analysis of genome-wide association by single markers and composite likelihood. Proc Natl Acad Sci U S A (2008) 0.82
Seizures on hearing the alarm clock. Lancet (2007) 0.81
A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern. Heart Rhythm (2012) 0.81
Torsades de Pointes: a rare complication of an extra-adrenal pheochromocytoma. Hypertens Res (2007) 0.80
Detection of anti-β1-AR autoantibodies in heart failure by a cell-based competition ELISA. Circ Res (2012) 0.79
Individuals with very low alcohol consumption: a heterogeneous group. J Stud Alcohol Drugs (2007) 0.79
Laminopathy presenting as familial atrial fibrillation. Int J Cardiol (2010) 0.79
Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features. BMC Neurol (2011) 0.78
Clinical utility gene card for: long-QT syndrome (types 1-13). Eur J Hum Genet (2013) 0.78
The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [18F]FDG PET. Eur J Nucl Med Mol Imaging (2013) 0.78
Electrocardiogram-gated 18F-FDG PET/CT hybrid imaging in patients with unsatisfactory response to cardiac resynchronization therapy: initial clinical results. J Nucl Med (2010) 0.77
MAPK= mitogen-activated protein KChIP2? Unraveling signaling pathways controlling cardiac Ito expression. Circ Res (2006) 0.77
Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events. Cardiovasc Ultrasound (2013) 0.76
Tuning the beat: differential expression of ion channels in the sinus node. Circ Res (2006) 0.75
Heart transplantation in a 36-year-old experiencing terminal heart failure caused by systemic sclerosis. Transplantation (2012) 0.75
Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet (2017) 0.75
Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nat Commun (2017) 0.75
Fifteen Genetic Loci Associated With the Electrocardiographic P Wave. Circ Cardiovasc Genet (2017) 0.75
Recurrent torsades de pointes after catheter ablation of incessant ventricular bigeminy in combination with QT prolongation. Europace (2011) 0.75
[Ventricular tachycardia : Treatment and prognostic significance]. Herzschrittmacherther Elektrophysiol (2013) 0.75
Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus noncardiologists. Results from the international prospective CLARIFY registry. Pol Arch Intern Med (2017) 0.75